Does Mounjaro Cause Vomiting?
Yes, vomiting is a reported side effect of Mounjaro (tirzepatide), a GLP-1/GIP receptor agonist for type 2 diabetes and weight management. Clinical trials showed nausea in 12-18% of patients, vomiting in 5-9%, and these often occur early in treatment, decreasing over time.[1][2]
How Common Is Vomiting with Mounjaro?
In SURMOUNT-1 (weight loss trial, n=2,539), vomiting affected 5% on 5mg, 9.3% on 10mg, and 8.1% on 15mg doses over 72 weeks. Rates were higher in SURPASS trials for diabetes (up to 10.7% on 15mg). Most cases are mild to moderate and resolve within weeks.[1][2]
Why Does Mounjaro Cause Vomiting?
It slows gastric emptying and affects gut hormones, leading to nausea/vomiting, especially at higher doses or during dose escalation. Starting low (2.5mg) and titrating slowly reduces risk.[2]
How Long Does Vomiting Last?
Typically 1-4 weeks after starting or increasing dose, but it can persist longer in some. About 1-3% discontinue due to GI issues.[1]
What Helps Prevent or Manage Vomiting?
- Take on empty stomach or with small meal.
- Stay hydrated; eat bland foods.
- Use anti-nausea meds like ondansetron if needed (consult doctor).
- Avoid rapid dose increases.[2]
When to Worry About Vomiting?
Seek medical help for severe/persistent vomiting, dehydration signs (dizziness, dry mouth), or blood in vomit. Rare risks include gastroparesis or pancreatitis.[2][3]
Mounjaro vs. Other GLP-1 Drugs on Vomiting
Higher vomiting rates than semaglutide (Ozempic/Wegovy: 3-5%) but similar to higher-dose tirzepatide profiles. Dual GLP-1/GIP action may intensify GI effects initially.[1][4]
Sources:
[1]: FDA Mounjaro Label
[2]: Eli Lilly SURMOUNT-1 Results
[3]: Drugs.com Mounjaro Side Effects
[4]: NEJM SURPASS-2 Comparison